{
  "hash": "64eae6382ef6d6dd63210f916063a026",
  "result": {
    "engine": "knitr",
    "markdown": "---\ntitle: \"Untitled\"\ndate: today\n---\n\n::: {.cell}\n\n```{.r .cell-code}\nlibrary(tidyverse)\n```\n\n::: {.cell-output .cell-output-stderr}\n\n```\n── Attaching core tidyverse packages ──────────────────────── tidyverse 2.0.0 ──\n✔ dplyr     1.1.3     ✔ readr     2.1.4\n✔ forcats   1.0.0     ✔ stringr   1.5.1\n✔ ggplot2   3.4.4     ✔ tibble    3.2.1\n✔ lubridate 1.9.3     ✔ tidyr     1.3.0\n✔ purrr     1.0.2     \n── Conflicts ────────────────────────────────────────── tidyverse_conflicts() ──\n✖ dplyr::filter() masks stats::filter()\n✖ dplyr::lag()    masks stats::lag()\nℹ Use the conflicted package (<http://conflicted.r-lib.org/>) to force all conflicts to become errors\n```\n\n\n:::\n\n```{.r .cell-code}\ndata <- RefManageR::ReadBib('publications.bib')\n\n# data <- data |> as_tibble()\n```\n:::\n\n::: {.cell}\n\n```{.r .cell-code}\ndata\n```\n\n::: {.cell-output .cell-output-stdout}\n\n```\n[1] J. C. Ahn, M. Lauzon, M. Luu, et al. \"Transarterial\nradioembolization versus systemic treatment for hepatocellular\ncarcinoma with macrovascular invasion: Analysis of the US National\nCancer Database\". Eng. In: _Journal of nuclear medicine : official\npublication, Society of Nuclear Medicine_ 62.12 (Apr. 2021), pp.\n1692-701. ISSN: 1535-5667. DOI: 10.2967/jnumed.121.261954. PMID:\n33837067.\n\n[2] E. M. Anderson, M. Luu, B. L. Balzer, et al. \"Variations in the\nassociation of grade with survival across the head and neck cancer\nlandscape\". Eng. In: _Head & neck_ 43.4 (Apr. 2021), pp. 1105-1115.\nISSN: 1097-0347. DOI: 10.1002/hed.26566. PMID: 33300641.\n\n[3] E. M. Anderson, M. Luu, E. M. Chung, et al. \"Re-examining\npredictors of pathologic lymph node positivity in clinically node\nnegative oral cavity cancer\". Eng. In: _Oral oncology_ 144 (Sep. 2023),\np. 106490. ISSN: 1879-0593. DOI: 10.1016/j.oraloncology.2023.106490.\nPMID: 37413770.\n\n[4] E. M. Anderson, M. Luu, and M. Kamrava. \"Demographic Factors\nPredict Risk of Lymph Node Involvement in Patients with Endometrial\nAdenocarcinoma\". Eng. In: _Biology_ 12.7 (Jul. 2023). ISSN: 2079-7737.\nDOI: 10.3390/biology12070982. PMID: 37508411.\n\n[5] E. M. Anderson, M. Luu, D. J. Lu, et al. \"Predicting Pathologic\nLymph Node Positivity in cN0 Pharynx and Larynx Cancers\". Eng. In: _The\nLaryngoscope_ 133.7 (Jul. 2023), pp. 1660-1666. ISSN: 1531-4995. DOI:\n10.1002/lary.30358. PMID: 36054029.\n\n[6] E. M. Anderson, M. Luu, D. J. Lu, et al. \"Pathologic primary tumor\nfactors associated with risk of lymph node involvement in patients with\nnon-endometrioid endometrial cancer\". Eng. In: _Gynecologic oncology_\n165.2 (May. 2022), pp. 281-286. ISSN: 1095-6859. DOI:\n10.1016/j.ygyno.2022.01.016. PMID: 35216809.\n\n[7] E. Anderson, M. Luu, A. S. Ho, et al. \"In Response to Predicting\nPathologic Lymph Node Positivity in cN0 Pharynx and Larynx Cancers\".\nEng. In: _The Laryngoscope_ 133.4 (Apr. 2023), p. E25. ISSN: 1531-4995.\nDOI: 10.1002/lary.30481. PMID: 36385470.\n\n[8] K. Aro, A. S. Ho, M. Luu, et al. \"Development of a novel salivary\ngland cancer lymph node staging system\". Eng. In: _Cancer_ 124.15 (Aug.\n2018), pp. 3171-3180. ISSN: 1097-0142. DOI: 10.1002/cncr.31535. PMID:\n29742277.\n\n[9] K. Aro, A. S. Ho, M. Luu, et al. \"Survival Impact of Adjuvant\nTherapy in Salivary Gland Cancers following Resection and Neck\nDissection\". Eng. In: _Otolaryngology-head and neck surgery : official\njournal of American Academy of Otolaryngology-Head and Neck Surgery_\n160.6 (Jun. 2019), pp. 1048-1057. ISSN: 1097-6817. DOI:\n10.1177/0194599819827851. PMID: 30721113.\n\n[10] L. Barrios, I. Shafqat, U. Alam, et al. \"Incidental\nparathyroidectomy in thyroidectomy and central neck dissection\". Eng.\nIn: _Surgery_ 169.5 (May. 2021), pp. 1145-1151. ISSN: 1532-7361. DOI:\n10.1016/j.surg.2020.11.023. PMID: 33446359.\n\n[11] V. F. Calsavara, N. L. Henry, R. D. Hays, et al. \"Dynamic Risk\nPrediction of Treatment Discontinuation Using Patient-Reported Outcomes\nData in the Phase III NSABP B-35 Trial\". Eng. In: _Cancer prevention\nresearch (Philadelphia, Pa.)_ 16.11 (Nov. 2023), pp. 631-639. ISSN:\n1940-6215. DOI: 10.1158/1940-6207.CAPR-23-0216. PMID: 37756580.\n\n[12] T. J. Daskivich, R. Gale, M. Luu, et al. \"Patient Preferences for\nCommunication of Life Expectancy in Prostate Cancer Treatment\nConsultations\". Eng. In: _JAMA surgery_ 157.1 (Jan. 2022), pp. 70-72.\nISSN: 2168-6262. DOI: 10.1001/jamasurg.2021.5803. PMID: 34757389.\n\n[13] T. J. Daskivich, R. Gale, M. Luu, et al. \"Variation in\nCommunication of Competing Risks of Mortality in Prostate Cancer\nTreatment Consultations\". Eng. In: _The Journal of urology_ 208.2 (Aug.\n2022), pp. 301-308. ISSN: 1527-3792. DOI: 10.1097/JU.0000000000002675.\nPMID: 35377775.\n\n[14] T. J. Daskivich, J. Houman, M. Lopez, et al. \"Association of\nWearable Activity Monitors With Assessment of Daily Ambulation and\nLength of Stay Among Patients Undergoing Major Surgery\". Eng. In: _JAMA\nnetwork open_ 2.2 (Feb. 2019), p. e187673. ISSN: 2574-3805. DOI:\n10.1001/jamanetworkopen.2018.7673. PMID: 30707226.\n\n[15] T. J. Daskivich, M. Luu, S. J. Freedland, et al. \"Development and\nValidation of an Improved Pathological Nodal Staging System in Men with\nProstate Cancer\". Eng. In: _The Journal of urology_ 207.3 (Mar. 2022),\npp. 581-591. ISSN: 1527-3792. DOI: 10.1097/JU.0000000000002256. PMID:\n34694160.\n\n[16] T. J. Daskivich, I. Thomas, M. Luu, et al. \"External Validation of\nthe Prostate Cancer Specific Comorbidity Index: A Claims Based Tool for\nthe Prediction of Life Expectancy in Men with Prostate Cancer\". Eng.\nIn: _The Journal of urology_ 202.3 (Sep. 2019), pp. 518-524. ISSN:\n1527-3792. DOI: 10.1097/JU.0000000000000287. PMID: 31009286.\n\n[17] T. Daskivich, M. Luu, B. Noah, et al. \"Differences in Online\nConsumer Ratings of Health Care Providers Across Medical, Surgical, and\nAllied Health Specialties: Observational Study of 212,933 Providers\".\nEng. In: _Journal of medical Internet research_ 20.5 (May. 2018), p.\ne176. ISSN: 1438-8871. DOI: 10.2196/jmir.9160. PMID: 29743150.\n\n[18] J. M. David, A. S. Ho, M. Luu, et al. \"Treatment at high-volume\nfacilities and academic centers is independently associated with\nimproved survival in patients with locally advanced head and neck\ncancer\". Eng. In: _Cancer_ 123.20 (Oct. 2017), pp. 3933-3942. ISSN:\n1097-0142. DOI: 10.1002/cncr.30843. PMID: 28640546.\n\n[19] J. David, M. Luu, D. Lu, et al. \"Outcomes with brachytherapy based\ndose escalation for gleason 8 versus 9-10 prostate cancer: An NCDB\nanalysis\". Eng. In: _Urologic oncology_ 39.12 (Dec. 2021), pp.\n829.e19-829.e26. ISSN: 1873-2496. DOI: 10.1016/j.urolonc.2021.04.014.\nPMID: 34049784.\n\n[20] M. A. Diniz, G. Gresham, S. Kim, et al. \"Visualizing adverse\nevents in clinical trials using correspondence analysis with R-package\nvisae\". Eng. In: _BMC medical research methodology_ 21.1 (Nov. 2021),\np. 244. ISSN: 1471-2288. DOI: 10.1186/s12874-021-01368-w. PMID:\n34753452.\n\n[21] R. Govalan, M. Lauzon, M. Luu, et al. \"Comparison of Surgical\nResection and Systemic Treatment for Hepatocellular Carcinoma with\nVascular Invasion: National Cancer Database Analysis\". Eng. In: _Liver\ncancer_ 10.5 (Sep. 2021), pp. 407-418. ISSN: 2235-1795. DOI:\n10.1159/000515554. PMID: 34721504.\n\n[22] R. Govalan, M. Luu, M. Lauzon, et al. \"Therapeutic Underuse and\nDelay in Hepatocellular Carcinoma: Prevalence, Associated Factors, and\nClinical Impact\". Eng. In: _Hepatology communications_ 6.1 (Jan. 2022),\npp. 223-236. ISSN: 2471-254X. DOI: 10.1002/hep4.1795. PMID: 34558830.\n\n[23] G. Gresham, M. A. Diniz, Z. S. Razaee, et al. \"Evaluating\nTreatment Tolerability in Cancer Clinical Trials Using the Toxicity\nIndex\". Eng. In: _Journal of the National Cancer Institute_ 112.12\n(Dec. 2020), pp. 1266-1274. ISSN: 1460-2105. DOI: 10.1093/jnci/djaa028.\nPMID: 32091598.\n\n[24] M. Guan, I. He, M. Luu, et al. \"Palliative Radiation Therapy for\nBone Metastases in Neuroendocrine Neoplasms\". Eng. In: _Advances in\nradiation oncology_ 4.3 (Apr. 2019), pp. 513-519. ISSN: 2452-1094. DOI:\n10.1016/j.adro.2019.03.014. PMID: 31360808.\n\n[25] N. L. Henry, S. Kim, R. D. Hays, et al. \"Toxicity Index,\nPatient-Reported Outcomes, and Early Discontinuation of Endocrine\nTherapy for Breast Cancer Risk Reduction in NRG Oncology/NSABP B-35\".\nEng. In: _Journal of clinical oncology : official journal of the\nAmerican Society of Clinical Oncology_ 39.34 (Dec. 2021), pp.\n3800-3812. ISSN: 1527-7755. DOI: 10.1200/JCO.21.00910. PMID: 34554865.\n\n[26] N. L. Henry, S. Kim, R. D. Hays, et al. \"Toxicity Index,\npatient-reported outcomes, and persistence of breast cancer\nchemotherapy-associated side effects in NRG Oncology/NSABP B-30\". Eng.\nIn: _NPJ breast cancer_ 8.1 (Nov. 2022), p. 123. ISSN: 2374-4677. DOI:\n10.1038/s41523-022-00489-9. PMID: 36402796.\n\n[27] A. S. Ho, M. Luu, B. L. Balzer, et al. \"Comparative impact of\ngrade on mortality across salivary cancers: A novel, unifying staging\nsystem\". Eng. In: _Head & neck_ 45.8 (Aug. 2023), pp. 2028-2039. ISSN:\n1097-0347. DOI: 10.1002/hed.27429. PMID: 37345665.\n\n[28] A. S. Ho, M. Luu, B. L. Balzer, et al. \"Reply to Letter to the\nEditor: Should there be a definite place for grade in the next TNM\nstaging system for (major) salivary gland malignancies?\" Eng. In: _Head\n& neck_ 45.10 (Oct. 2023), pp. 2742-2743. ISSN: 1097-0347. DOI:\n10.1002/hed.27501. PMID: 37650152.\n\n[29] A. S. Ho, M. Luu, L. Barrios, et al. \"Prognostic Impact of\nHistologic Grade for Papillary Thyroid Carcinoma\". Eng. In: _Annals of\nsurgical oncology_ 28.3 (Mar. 2021), pp. 1731-1739. ISSN: 1534-4681.\nDOI: 10.1245/s10434-020-09023-2. PMID: 32808161.\n\n[30] A. S. Ho, M. Luu, L. Barrios, et al. \"Incidence and Mortality Risk\nSpectrum Across Aggressive Variants of Papillary Thyroid Carcinoma\".\nEng. In: _JAMA oncology_ 6.5 (May. 2020), pp. 706-713. ISSN: 2374-2445.\nDOI: 10.1001/jamaoncol.2019.6851. PMID: 32134428.\n\n[31] A. S. Ho, M. Luu, S. Kim, et al. \"Nodal staging convergence for\nHPV- and HPV+ oropharyngeal carcinoma\". Eng. In: _Cancer_ 127.10 (May.\n2021), pp. 1590-1597. ISSN: 1097-0142. DOI: 10.1002/cncr.33414. PMID:\n33595897.\n\n[32] A. S. Ho, M. Luu, I. Shafqat, et al. \"Predictive Impact of\nMetastatic Lymph Node Burden on Distant Metastasis Across Papillary\nThyroid Cancer Variants\". Eng. In: _Thyroid : official journal of the\nAmerican Thyroid Association_ 31.10 (Oct. 2021), pp. 1549-1557. ISSN:\n1557-9077. DOI: 10.1089/thy.2021.0131. PMID: 34470466.\n\n[33] A. S. Ho, M. Luu, C. Zalt, et al. \"Mortality Risk of Nonoperative\nPapillary Thyroid Carcinoma: A Corollary for Active Surveillance\". Eng.\nIn: _Thyroid : official journal of the American Thyroid Association_\n29.10 (Oct. 2019), pp. 1409-1417. ISSN: 1557-9077. DOI:\n10.1089/thy.2019.0060. PMID: 31407637.\n\n[34] M. Kaisey, A. J. Solomon, B. L. Guerrero, et al. \"Preventing\nmultiple sclerosis misdiagnosis using the \"central vein sign\": A\nreal-world study\". Eng. In: _Multiple sclerosis and related disorders_\n48 (Feb. 2021), p. 102671. ISSN: 2211-0356. DOI:\n10.1016/j.msard.2020.102671. PMID: 33444958.\n\n[35] M. Kaisey, A. J. Solomon, M. Luu, et al. \"Incidence of multiple\nsclerosis misdiagnosis in referrals to two academic centers\". Eng. In:\n_Multiple sclerosis and related disorders_ 30 (May. 2019), pp. 51-56.\nISSN: 2211-0356. DOI: 10.1016/j.msard.2019.01.048. PMID: 30738280.\n\n[36] P. K. Kuhlmann, M. Chen, M. Luu, et al. \"Predictors of disparity\nbetween targeted and in-zone systematic cores during transrectal\nMR/US-fusion prostate biopsy\". Eng. In: _Urologic oncology_ 40.4 (Apr.\n2022), pp. 162.e1-162.e7. ISSN: 1873-2496. DOI:\n10.1016/j.urolonc.2021.12.016. PMID: 35067431.\n\n[37] P. K. Kuhlmann, M. Chen, M. Luu, et al. \"Patient- and tumor-level\nrisk factors for MRI-invisible prostate cancer\". Eng. In: _Prostate\ncancer and prostatic diseases_ 24.3 (Sep. 2021), pp. 794-801. ISSN:\n1476-5608. DOI: 10.1038/s41391-021-00330-7. PMID: 33568751.\n\n[38] Y. Lee, A. G. Singal, M. Lauzon, et al. \"Disparities in curative\ntreatments and outcomes for early stage intrahepatic cholangiocarcinoma\nin the United States\". Eng. In: _Cancer_ 128.20 (Oct. 2022), pp.\n3610-3619. ISSN: 1097-0142. DOI: 10.1002/cncr.34436. PMID: 35997126.\n\n[39] Y. Lee, J. J. Wang, M. Luu, et al. \"The Mortality and Overall\nSurvival Trends of Primary Liver Cancer in the United States\". Eng. In:\n_Journal of the National Cancer Institute_ 113.11 (Nov. 2021), pp.\n1531-1541. ISSN: 1460-2105. DOI: 10.1093/jnci/djab079. PMID: 34010422.\n\n[40] Y. Lee, J. J. Wang, M. Luu, et al. \"Comparison of Clinical\nFeatures and Outcomes Between Intrahepatic Cholangiocarcinoma and\nHepatocellular Carcinoma in the United States\". Eng. In: _Hepatology\n(Baltimore, Md.)_ 74.5 (Nov. 2021), pp. 2622-2632. ISSN: 1527-3350.\nDOI: 10.1002/hep.32007. PMID: 34114675.\n\n[41] Y. Lee, J. J. Wang, M. Luu, et al. \"State-Level HCC Incidence and\nAssociation With Obesity and Physical Activity in the United States\".\nEng. In: _Hepatology (Baltimore, Md.)_ 74.3 (Sep. 2021), pp. 1384-1394.\nISSN: 1527-3350. DOI: 10.1002/hep.31811. PMID: 33728665.\n\n[42] D. J. Lu, M. Luu, C. Gay, et al. \"Nodal Metastasis Count and\nOncologic Outcomes in Head and Neck Cancer: A Secondary Analysis of\nNRG/RTOG 9501, NRG/RTOG 0234, and EORTC 22931\". Eng. In: _International\njournal of radiation oncology, biology, physics_ 113.4 (Jul. 2022), pp.\n787-795. ISSN: 1879-355X. DOI: 10.1016/j.ijrobp.2022.03.033. PMID:\n35395358.\n\n[43] D. J. Lu, M. Luu, A. Mita, et al. \"Human papillomavirus-associated\noropharyngeal cancer among patients aged 70 and older: Dramatically\nincreased prevalence and clinical implications\". Eng. In: _European\njournal of cancer (Oxford, England : 1990)_ 103 (Nov. 2018), pp.\n195-204. ISSN: 1879-0852. DOI: 10.1016/j.ejca.2018.08.015. PMID:\n30268920.\n\n[44] D. J. Lu, M. Luu, A. T. Nguyen, et al. \"Survival outcomes with\nconcomitant chemoradiotherapy in older adults with oropharyngeal\ncarcinoma in an era of increasing human papillomavirus (HPV)\nprevalence\". Eng. In: _Oral oncology_ 99 (Dec. 2019), p. 104472. ISSN:\n1879-0593. DOI: 10.1016/j.oraloncology.2019.104472. PMID: 31704556.\n\n[45] D. J. Lu, M. Luu, A. T. Nguyen, et al. \"The role of concomitant\nchemoradiotherapy in AJCC 7th edition T1-2N1 oropharyngeal carcinoma in\nthe human papillomavirus era\". Eng. In: _Oral oncology_ 110 (Nov.\n2020), p. 104882. ISSN: 1879-0593. DOI:\n10.1016/j.oraloncology.2020.104882. PMID: 32650257.\n\n[46] D. J. Lu, M. Luu, C. M. Yashar, et al. \"An evaluation of gender\ndiversity in the American Brachytherapy Society\". Eng. In:\n_Brachytherapy_ 18.6 (Aug. 2019), pp. 835-840. ISSN: 1873-1449. DOI:\n10.1016/j.brachy.2019.07.003. PMID: 31402211.\n\n[47] S. R. Marcrom, J. M. Kahn, L. E. Colbert, et al. \"Brachytherapy\nTraining Survey of Radiation Oncology Residents\". Eng. In:\n_International journal of radiation oncology, biology, physics_ 103.3\n(Mar. 2019), pp. 557-560. ISSN: 1879-355X. DOI:\n10.1016/j.ijrobp.2018.10.023. PMID: 30612963.\n\n[48] J. L. Markman, R. A. Porritt, D. Wakita, et al. \"Loss of\ntestosterone impairs anti-tumor neutrophil function\". Eng. In: _Nature\ncommunications_ 11.1 (Mar. 2020), p. 1613. ISSN: 2041-1723. DOI:\n10.1038/s41467-020-15397-4. PMID: 32235862.\n\n[49] J. M. Masterson, M. Luu, A. Naser-Tavakolian, et al. \"Concurrent\nprognostic utility of lymph node count and lymph node density for men\nwith pathological node-positive prostate cancer\". Eng. In: _Prostate\ncancer and prostatic diseases_ (Jan. 2023). ISSN: 1476-5608. DOI:\n10.1038/s41391-022-00635-1. PMID: 36600045.\n\n[50] A. Naser-Tavakolian, R. Gale, M. Luu, et al. \"Use of Persuasive\nLanguage in Communication of Risk during Prostate Cancer Treatment\nConsultations\". Eng. In: _Medical decision making : an international\njournal of the Society for Medical Decision Making_ (Feb. 2024), p.\n272989X241228612. ISSN: 1552-681X. DOI: 10.1177/0272989X241228612.\nPMID: 38347686.\n\n[51] A. T. Nguyen, M. Luu, J. M. Clair, et al. \"Comparison of Survival\nAfter Transoral Robotic Surgery vs Nonrobotic Surgery in Patients With\nEarly-Stage Oropharyngeal Squamous Cell Carcinoma\". Eng. In: _JAMA\noncology_ 6.10 (Oct. 2020), pp. 1555-1562. ISSN: 2374-2445. DOI:\n10.1001/jamaoncol.2020.3172. PMID: 32816023.\n\n[52] A. T. Nguyen, M. Luu, D. J. Lu, et al. \"Quantitative metastatic\nlymph node burden and survival in Merkel cell carcinoma\". Eng. In:\n_Journal of the American Academy of Dermatology_ 84.2 (Feb. 2021), pp.\n312-320. ISSN: 1097-6787. DOI: 10.1016/j.jaad.2019.12.072. PMID:\n31954753.\n\n[53] A. T. Nguyen, M. Luu, V. P. Nguyen, et al. \"Development and\nValidation of a Modified Pathologic Nodal Classification System for\nCutaneous Melanoma\". Eng. In: _JAMA surgery_ 156.11 (Nov. 2021), p.\ne214298. ISSN: 2168-6262. DOI: 10.1001/jamasurg.2021.4298. PMID:\n34468697.\n\n[54] A. T. Nguyen, M. Luu, V. P. Nguyen, et al. \"Quantitative Nodal\nBurden and Mortality Across Solid Cancers\". Eng. In: _Journal of the\nNational Cancer Institute_ 114.7 (Jul. 2022), pp. 1003-1011. ISSN:\n1460-2105. DOI: 10.1093/jnci/djac059. PMID: 35311991.\n\n[55] X. Ni, M. Luu, W. Ma, et al. \"Impact of Asian Race on Prognosis in\nDe Novo Metastatic Prostate Cancer\". Eng. In: _Journal of the National\nComprehensive Cancer Network : JNCCN_ 21.7 (Jul. 2023), pp. 733-741.e3.\nISSN: 1540-1413. DOI: 10.6004/jnccn.2023.7027. PMID: 37433430.\n\n[56] D. N. Patel, S. I. Felder, M. Luu, et al. \"Early Urinary Catheter\nRemoval Following Pelvic Colorectal Surgery: A Prospective, Randomized,\nNoninferiority Trial\". Eng. In: _Diseases of the colon and rectum_\n61.10 (Oct. 2018), pp. 1180-1186. ISSN: 1530-0358. DOI:\n10.1097/DCR.0000000000001206. PMID: 30192326.\n\n[57] D. N. Patel, M. Luu, Z. S. Zumsteg, et al. \"Development and\nValidation of an Improved Pathological Nodal Staging System for\nUrothelial Carcinoma of the Bladder\". Eng. In: _European urology\noncology_ 2.6 (Nov. 2019), pp. 656-663. ISSN: 2588-9311. DOI:\n10.1016/j.euo.2018.12.012. PMID: 31412014.\n\n[58] D. N. Patel, M. Luu, Z. S. Zumsteg, et al. \"Use of Bladder Sparing\nSurgery for Muscle Invasive Bladder Cancer by Life Expectancy at\nDiagnosis\". Eng. In: _Urology practice_ 8.1 (Jan. 2021), pp. 94-99.\nISSN: 2352-0787. DOI: 10.1097/UPJ.0000000000000146. PMID: 37145435.\n\n[59] J. D. Pennington, F. C. Eilber, F. R. Eilber, et al. \"Long-term\nOutcomes With Ifosfamide-based Hypofractionated Preoperative\nChemoradiotherapy for Extremity Soft Tissue Sarcomas\". Eng. In:\n_American journal of clinical oncology_ 41.12 (Dec. 2018), pp.\n1154-1161. ISSN: 1537-453X. DOI: 10.1097/COC.0000000000000443. PMID:\n29664796.\n\n[60] A. Shinde, B. Jones, M. Luu, et al. \"Factors predictive of 90-day\nmortality after surgical resection for oral cavity cancer: Development\nof a recursive partitioning analysis for risk stratification\". Eng. In:\n_Head & neck_ 43.9 (Sep. 2021), pp. 2731-2739. ISSN: 1097-0347. DOI:\n10.1002/hed.26740. PMID: 34013577.\n\n[61] M. P. Sittig, M. Luu, E. J. Yoshida, et al. \"Impact of insurance\non survival in patients < 65 with head & neck cancer treated with\nradiotherapy\". Eng. In: _Clinical otolaryngology : official journal of\nENT-UK ; official journal of Netherlands Society for\nOto-Rhino-Laryngology & Cervico-Facial Surgery_ 45.1 (Jan. 2020), pp.\n63-72. ISSN: 1749-4486. DOI: 10.1111/coa.13467. PMID: 31661188.\n\n[62] M. K. Srour, M. Lee, S. Walcott-Sapp, et al. \"Overuse of\nPreoperative Staging of Patients Undergoing Neoadjuvant Chemotherapy\nfor Breast Cancer\". Eng. In: _Annals of surgical oncology_ 26.10 (Oct.\n2019), pp. 3289-3294. ISSN: 1534-4681. DOI: 10.1245/s10434-019-07543-0.\nPMID: 31342365.\n\n[63] M. K. Srour, M. Lee, S. Wolcott-Sapp, et al. \"Incidental\nradiologic findings in breast cancer patients who undergo staging prior\nto neo-adjuvant chemotherapy\". Eng. In: _The breast journal_ 27.4 (Apr.\n2021), pp. 345-351. ISSN: 1524-4741. DOI: 10.1111/tbj.14172. PMID:\n33491830.\n\n[64] M. K. Srour, J. Tseng, M. Luu, et al. \"Patterns in the Use of\nAxillary Operations for Patients with Node-Positive Breast Cancer After\nNeoadjuvant Chemotherapy: A National Cancer Database (NCDB) Analysis\".\nEng. In: _Annals of surgical oncology_ 26.10 (Oct. 2019), pp.\n3305-3311. ISSN: 1534-4681. DOI: 10.1245/s10434-019-07540-3. PMID:\n31342364.\n\n[65] M. Tam, M. Luu, C. A. Barker, et al. \"Improved survival in women\nversus men with merkel cell carcinoma\". Eng. In: _Journal of the\nAmerican Academy of Dermatology_ 84.2 (Feb. 2021), pp. 321-329. ISSN:\n1097-6787. DOI: 10.1016/j.jaad.2020.02.034. PMID: 32423829.\n\n[66] K. Vaculik, M. Luu, L. E. Howard, et al. \"Time Trends in Use of\nRadical Prostatectomy by Tumor Risk and Life Expectancy in a National\nVeterans Affairs Cohort\". Eng. In: _JAMA network open_ 4.6 (Jun. 2021),\np. e2112214. ISSN: 2574-3805. DOI: 10.1001/jamanetworkopen.2021.12214.\nPMID: 34081138.\n\n[67] A. Vipani, M. Lauzon, M. Luu, et al. \"Decreasing Trend of Serum\nα-Fetoprotein Level in Hepatocellular Carcinoma\". Eng. In: _Clinical\ngastroenterology and hepatology : the official clinical practice\njournal of the American Gastroenterological Association_ 20.5 (May.\n2022), pp. 1177-1179.e4. ISSN: 1542-7714. DOI:\n10.1016/j.cgh.2021.08.011. PMID: 34391921.\n\n[68] S. Walcott-Sapp, M. K. Srour, M. Lee, et al. \"Can Radiologic Tumor\nSize Following Neoadjuvant Therapy Reliably Guide Tissue Resection in\nBreast Conserving Surgery in Patients with Invasive Breast Cancer?\"\nEng. In: _The American surgeon_ 86.10 (Oct. 2020), pp. 1248-1253. ISSN:\n1555-9823. DOI: 10.1177/0003134820964209. PMID: 33284669.\n\n[69] J. D. Yang, M. Luu, A. G. Singal, et al. \"Factors Associated With\nDetection and Survival of T1 Hepatocellular Carcinoma in the United\nStates: National Cancer Database Analysis\". Eng. In: _Journal of the\nNational Comprehensive Cancer Network : JNCCN_ 18.9 (Sep. 2020), pp.\n1210-1220. ISSN: 1540-1413. DOI: 10.6004/jnccn.2020.7564. PMID:\n32886898.\n\n[70] Y. H. Yeo, J. Liang, M. Lauzon, et al. \"Immunotherapy and\nTransarterial Radioembolization Combination Treatment for Advanced\nHepatocellular Carcinoma\". Eng. In: _The American journal of\ngastroenterology_ 118.12 (Dec. 2023), pp. 2201-2211. ISSN: 1572-0241.\nDOI: 10.14309/ajg.0000000000002467. PMID: 37561061.\n\n[71] E. J. Yoshida, M. Luu, J. M. Clair, et al. \"Stage I HPV-positive\noropharyngeal cancer: Should all patients receive similar treatments?\"\nEng. In: _Cancer_ 126.1 (Jan. 2020), pp. 58-66. ISSN: 1097-0142. DOI:\n10.1002/cncr.32501. PMID: 31536144.\n\n[72] E. J. Yoshida, M. Luu, J. M. David, et al. \"Postoperative\nchemoradiotherapy in patients with head and neck cancer aged 70 or\nolder with positive margins or extranodal extension and the influence\nof nodal classification\". Eng. In: _Head & neck_ 40.6 (Jun. 2018), pp.\n1228-1236. ISSN: 1097-0347. DOI: 10.1002/hed.25100. PMID: 29417700.\n\n[73] E. J. Yoshida, M. Luu, J. M. David, et al. \"Facility Volume and\nSurvival in Nasopharyngeal Carcinoma\". Eng. In: _International journal\nof radiation oncology, biology, physics_ 100.2 (Feb. 2018), pp.\n408-417. ISSN: 1879-355X. DOI: 10.1016/j.ijrobp.2017.09.038. PMID:\n29100787.\n\n[74] E. J. Yoshida, M. Luu, M. Freeman, et al. \"The association between\nfacility volume and overall survival in patients with Merkel cell\ncarcinoma\". Eng. In: _Journal of surgical oncology_ 122.2 (Aug. 2020),\npp. 254-262. ISSN: 1096-9098. DOI: 10.1002/jso.25931. PMID: 32297324.\n\n[75] H. H. Zhao, M. Luu, B. Spiegel, et al. \"Correlation of Online\nPhysician Rating Subscores and Association With Overall Satisfaction:\nObservational Study of 212,933 Providers\". Eng. In: _Journal of medical\nInternet research_ 22.10 (Oct. 2020), p. e11258. ISSN: 1438-8871. DOI:\n10.2196/11258. PMID: 33107826.\n\n[76] Z. S. Zumsteg, M. Luu, P. S. Rosenberg, et al. \"Global\nepidemiologic patterns of oropharyngeal cancer incidence trends\". Eng.\nIn: _Journal of the National Cancer Institute_ 115.12 (Dec. 2023), pp.\n1544-1554. ISSN: 1460-2105. DOI: 10.1093/jnci/djad169. PMID: 37603716.\n\n[77] Z. S. Zumsteg, M. Luu, E. J. Yoshida, et al. \"Combined\nhigh-intensity local treatment and systemic therapy in metastatic head\nand neck squamous cell carcinoma: An analysis of the National Cancer\nData Base\". Eng. In: _Cancer_ 123.23 (Dec. 2017), pp. 4583-4593. ISSN:\n1097-0142. DOI: 10.1002/cncr.30933. PMID: 28817183.\n\n[78] Z. S. Zumsteg, D. E. Spratt, T. J. Daskivich, et al. \"Effect of\nAndrogen Deprivation on Long-term Outcomes of Intermediate-Risk\nProstate Cancer Stratified as Favorable or Unfavorable: A Secondary\nAnalysis of the RTOG 9408 Randomized Clinical Trial\". Eng. In: _JAMA\nnetwork open_ 3.9 (Sep. 2020), p. e2015083. ISSN: 2574-3805. DOI:\n10.1001/jamanetworkopen.2020.15083. PMID: 32902647.\n```\n\n\n:::\n:::\n",
    "supporting": [],
    "filters": [
      "rmarkdown/pagebreak.lua"
    ],
    "includes": {},
    "engineDependencies": {},
    "preserve": {},
    "postProcess": true
  }
}